Insider Transactions in Q1 2021 at Kiora Pharmaceuticals Inc (KPRX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.18%
|
$960
$5.46 P/Share
|
|
Mar 03
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.18%
|
$960
$5.46 P/Share
|
|
Mar 03
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.9%
|
$1,090
$5.46 P/Share
|
|
Mar 03
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
898
-1.22%
|
$4,490
$5.46 P/Share
|
|
Feb 02
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,282
-5.01%
|
$7,692
$6.34 P/Share
|
|
Feb 02
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
3,542
-4.58%
|
$21,252
$6.34 P/Share
|
|
Feb 02
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-5.73%
|
$5,928
$6.34 P/Share
|
|
Feb 02
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
990
-5.73%
|
$5,940
$6.34 P/Share
|
|
Jan 06
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 06
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,531,101
+31.39%
|
$7,655,505
$5.22 P/Share
|
|
Jan 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.66%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.66%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.45%
|
$460
$4.85 P/Share
|
|
Jan 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
705
-0.9%
|
$2,820
$4.85 P/Share
|